Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • Author FAQs
    • Open access
    • COVID-19 submission information
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • Author FAQs
    • Open access
    • COVID-19 submission information
  • Alerts
  • Podcasts
  • Subscriptions

Latent tuberculosis screening and treatment among asylum seekers: a mixed-methods study

Ineke Spruijt, Dawit Tesfay Haile, Jeanine Suurmond, Susan van den Hof, Marga Koenders, Peter Kouw, Natascha van Noort, Sophie Toumanian, Frank Cobelens, Simone Goosen, Connie Erkens
European Respiratory Journal 2019 54: 1900861; DOI: 10.1183/13993003.00861-2019
Ineke Spruijt
1KNCV Tuberculosis Foundation, The Hague, The Netherlands
2Dept of Public Health, Amsterdam Public Health Research Institute, Amsterdam University Medical Centre, University of Amsterdam, Amsterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ineke Spruijt
  • For correspondence: ineke.spruijt@kncvtbc.org
Dawit Tesfay Haile
2Dept of Public Health, Amsterdam Public Health Research Institute, Amsterdam University Medical Centre, University of Amsterdam, Amsterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeanine Suurmond
2Dept of Public Health, Amsterdam Public Health Research Institute, Amsterdam University Medical Centre, University of Amsterdam, Amsterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Susan van den Hof
1KNCV Tuberculosis Foundation, The Hague, The Netherlands
3National Institute for Public Health and the Environment (RIVM), Centre for Infectious Disease Control, Bilthoven, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marga Koenders
4Dept of Tuberculosis Control, Public Health Service Gelderland Zuid, Nijmegen, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Kouw
5Dept of Tuberculosis Control, Public Health Service Flevoland, Lelystad, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Natascha van Noort
6Dept of Tuberculosis Control, Public Health Service Region Utrecht, Utrecht, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sophie Toumanian
7Dept of Tuberculosis Control, Public Health Service Twente, Enschede, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frank Cobelens
8Dept of Global Health and Amsterdam Institute for Global Health and Development, Amsterdam University Medical Center, Amsterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Simone Goosen
9Netherlands Association of Community Health Services (GGD GHOR Nederland), Utrecht, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Connie Erkens
1KNCV Tuberculosis Foundation, The Hague, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Introduction Evidence on conditions for implementation of latent tuberculosis infection (LTBI) screening and treatment among asylum seekers is needed to inform tuberculosis (TB) control policies. We used mixed-methods to evaluate the implementation of an LTBI screening and treatment programme among asylum seekers in the Netherlands.

Methods We offered voluntary LTBI screening to asylum seekers aged ≥12 years living in asylum seeker centres from countries with a TB incidence >200 per 10 000 population. We calculated LTBI screening and treatment cascade coverage, and assessed associated factors with Poisson regression using robust variance estimators. We interviewed TB care staff (seven group interviews) and Eritrean clients (21 group and 21 individual interviews) to identify programme enhancers and barriers.

Results We screened 719 (63% of 1136) clients for LTBI. LTBI was diagnosed among 178 (25%) clients; 149 (84%) initiated LTBI treatment, of whom 129 (87%) completed treatment. In-person TB and LTBI education, the use of professional interpreters, and collaboration with partner organisations were enhancers for LTBI screening uptake. Demand-driven LTBI treatment support by TB nurses enhanced treatment completion. Factors complicating LTBI screening and treatment were having to travel to public health services, language barriers and moving from asylum seeker centres to the community during treatment.

Conclusion LTBI screening and treatment of asylum seekers is feasible and effective when high quality of care is provided, including culture-sensitive TB education throughout the care cascade. Additionally, collaboration with partner organisations, such as agencies responsible for reception and support of asylum seekers, should be in place.

Abstract

LTBI screening and treatment among asylum seekers is feasible and effective when high quality of care is provided, including special attention for culture-sensitive education about TB and LTBI and collaboration with partner organisations http://bit.ly/2Lf6Y1I

Footnotes

  • This article has supplementary material available from erj.ersjournals.com

  • Data availability: The data supporting the results of this study were obtained from multiple sources. We received permission from these sources to use the data for this study purpose, including publishing results of the study. However, no permission was sought to publish an anonymous dataset. Therefore, anonymous data supporting the study results can be made available only upon request, upon approval by the Dutch National Tuberculosis Registration Committee.

  • Author contributions: I. Spruijt wrote the study protocol in collaboration with the other authors, performed data management and analyses, and wrote the manuscript. D. Tesfay Haile conducted and transcribed interviews with Eritrean clients, and supported in qualitative data analyses and interpretation. C. Erkens was daily supervisor of I. Spruijt and approved the study protocol. J. Suurmond supervised the qualitative research of this study. S. van den Hof supervised the epidemiological component of this study and approved the study protocol. F. Cobelens provided input on all aspects of the study process. M. Koenders, P. Kouw, N. van Noort and S. Toumanian were coordinators of the study at their PHS. S. Goosen advised on the study process. All authors read, commented on and approved the final manuscript.

  • Conflict of interest: I. Spruijt reports grants and other from KNCV Tuberculosis Foundation, during the conduct of the study.

  • Conflict of interest: D. Tesfay Haile has nothing to disclose.

  • Conflict of interest: J. Suurmond has nothing to disclose.

  • Conflict of interest: S. van den Hof has nothing to disclose.

  • Conflict of interest: M. Koenders has nothing to disclose.

  • Conflict of interest: P. Kouw has nothing to disclose.

  • Conflict of interest: N. van Noort has nothing to disclose.

  • Conflict of interest: S. Toumanian has nothing to disclose.

  • Conflict of interest: F. Cobelens has nothing to disclose.

  • Conflict of interest: S. Goosen has nothing to disclose.

  • Conflict of interest: C. Erkens has nothing to disclose.

  • Support statement: This work was supported by the Netherlands Organisation for Health Research and Development (ZonMW; grant 50-53000-98-128). Qiagen provided the QuantiFERON-TB Gold Plus kits free of charge. Qiagen read the final manuscript. Neither ZonMW nor Qiagen had a role in the study design, data collection and analysis, decision to publish or preparation of the manuscript. Funding information for this article has been deposited with the Crossref Funder Registry.

  • Received April 30, 2019.
  • Accepted August 26, 2019.
  • Copyright ©ERS 2019
https://www.ersjournals.com/user-licence
View Full Text

ERS Members

myERS - ERS members : log in with your myERS username and password.

INDIVIDUALS

Log in Login as an individual user.

Forgot your username or password?

LIBRARY USERS

Log in through your institution

If your library has a subscription, you may already be logged in via your IP address. Otherwise you may be able to log in via one of the following routes.
You may be able to gain access using your login credentials for your institution. Contact your library if you do not have a username and password.
If your organization uses OpenAthens, you can log in using your OpenAthens username and password. To check if your institution is supported, please see this list. Contact your library for more details.
If you think you should have access, please contact your librarian or email journals@ersnet.org

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top
View this article with LENS
Vol 54 Issue 5 Table of Contents
European Respiratory Journal: 54 (5)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Latent tuberculosis screening and treatment among asylum seekers: a mixed-methods study
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
Latent tuberculosis screening and treatment among asylum seekers: a mixed-methods study
Ineke Spruijt, Dawit Tesfay Haile, Jeanine Suurmond, Susan van den Hof, Marga Koenders, Peter Kouw, Natascha van Noort, Sophie Toumanian, Frank Cobelens, Simone Goosen, Connie Erkens
European Respiratory Journal Nov 2019, 54 (5) 1900861; DOI: 10.1183/13993003.00861-2019

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Latent tuberculosis screening and treatment among asylum seekers: a mixed-methods study
Ineke Spruijt, Dawit Tesfay Haile, Jeanine Suurmond, Susan van den Hof, Marga Koenders, Peter Kouw, Natascha van Noort, Sophie Toumanian, Frank Cobelens, Simone Goosen, Connie Erkens
European Respiratory Journal Nov 2019, 54 (5) 1900861; DOI: 10.1183/13993003.00861-2019
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Abstract
    • Introduction
    • Materials and methods
    • Results
    • Discussion
    • Supplementary material
    • Shareable PDF
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • Respiratory infections and tuberculosis
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

Original Articles

  • Maternal antibiotic use during pregnancy and asthma in children
  • Hyperglycaemia in cystic fibrosis adversely affects BK channel function
  • Validation of Lung EpiCheck for the detection of lung cancer
Show more Original Articles

Tuberculosis

  • Whole genome sequencing for MTB in Europe
  • Changes in treatment for MDR-TB according to national income
  • Towards elimination of childhood TB in the Netherlands
Show more Tuberculosis

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • CME
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Submit a manuscript
  • ERS author centre

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2021 by the European Respiratory Society